|
1
|
Stupp R, Mason WP, van den Bent MJ, et al:
Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sameshima T, Nabeshima K, Toole BP, et al:
Glioma cell extracellular matrix metalloproteinase inducer
(EMMPRIN) (CD147) stimulates production of membrane-type matrix
metalloproteinases and activated gelatinase A in co-cultures with
brain-derived fibroblasts. Cancer Lett. 157:177–184. 2000.
View Article : Google Scholar
|
|
3
|
Visse R and Nagase H: Matrix
metalloproteinases and tissue inhibitors of metalloproteinases:
structure, function, and biochemistry. Circ Res. 92:827–839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagase H, Visse R and Murphy G: Structure
and function of matrix metalloproteinases and TIMPs. Cardiovasc
Res. 69:562–573. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alajez NM, Lenarduzzi M, Ito E, et al:
MiR-218 suppresses nasopharyngeal cancer progression through
downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res.
71:2381–2391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Crawford HC, Fingleton BM, Rudolph-Owen
LA, et al: The metalloproteinase matrilysin is a target of
beta-catenin transactivation in intestinal tumors. Oncogene.
18:2883–2891. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu B, Crampton SP and Hughes CC: Wnt
signaling induces matrix metalloproteinase expression and regulates
T cell transmigration. Immunity. 26:227–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan W, Zhang W, Sun L, et al:
Identification of MMP-9 specific microRNA expression profile as
potential targets of anti-invasion therapy in glioblastoma
multiforme. Brain Res. 1411:108–115. 2011.PubMed/NCBI
|
|
10
|
Zhang J, Han L, Zhang A, et al: AKT2
expression is associated with glioma malignant progression and
required for cell survival and invasion. Oncol Rep. 24:65–72.
2010.PubMed/NCBI
|
|
11
|
Birner P, Toumangelova-Uzeir K, Natchev S
and Guentchev M: STAT3 tyrosine phosphorylation influences survival
in glioblastoma. J Neurooncol. 100:339–343. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Chen L, Bao Z, et al: Inhibition
of STAT3 reverses alkylator resistance through modulation of the
AKT and beta-catenin signaling pathways. Oncol Rep. 26:1173–1180.
2011.PubMed/NCBI
|
|
13
|
Debinski W and Gibo DM: Fos-related
antigen 1 modulates malignant features of glioma cells. Mol Cancer
Res. 3:237–249. 2005.PubMed/NCBI
|
|
14
|
Zhou X, Ren Y, Moore L, et al:
Downregulation of miR-21 inhibits EGFR pathway and suppresses the
growth of human glioblastoma cells independent of PTEN status. Lab
Invest. 90:144–155. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tie J, Pan Y, Zhao L, et al: MiR-218
inhibits invasion and metastasis of gastric cancer by targeting the
Robo1 receptor. PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rao SA, Santosh V and Somasundaram K:
Genome-wide expression profiling identifies deregulated miRNAs in
malignant astrocytoma. Mod Pathol. 23:1404–1417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Silber J, Lim DA, Petritsch C, et al:
miR-124 and miR-137 inhibit proliferation of glioblastoma
multiforme cells and induce differentiation of brain tumor stem
cells. BMC Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ingraham CA, Park GC, Makarenkova HP and
Crossin KL: Matrix metalloproteinase (MMP)-9 induced by Wnt
signaling increases the proliferation and migration of embryonic
neural stem cells at low O2 levels. J Biol Chem.
286:17649–17657. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Collier IE, Legant W, Marmer B, et al:
Diffusion of MMPs on the surface of collagen fibrils: the mobile
cell surface-collagen substratum interface. PLoS One. 6:e240292011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Uddin S, Hussain AR, Siraj AK, et al: Role
of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large
B-cell lymphoma survival. Blood. 108:4178–4186. 2006.
|
|
22
|
Hou J, Lin L, Zhou W, et al:
Identification of miRNomes in human liver and hepatocellular
carcinoma reveals miR-199a/b-3p as therapeutic target for
hepatocellular carcinoma. Cancer Cell. 19:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi W, Gerster K, Alajez NM, et al:
MicroRNA-301 mediates proliferation and invasion in human breast
cancer. Cancer Res. 71:2926–2937. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun D, Lee YS, Malhotra A, et al: miR-99
family of MicroRNAs suppresses the expression of prostate-specific
antigen and prostate cancer cell proliferation. Cancer Res.
71:1313–1324. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saydam O, Shen Y, Wurdinger T, et al:
Downregulated microRNA-200a in meningiomas promotes tumor growth by
reducing E-cadherin and activating the Wnt/beta-catenin signaling
pathway. Mol Cell Biol. 29:5923–5940. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maiese K, Li F, Chong ZZ and Shang YC: The
Wnt signaling pathway: aging gracefully as a protectionist?
Pharmacol Ther. 118:58–81. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He TC, Sparks AB, Rago C, et al:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shtutman M, Zhurinsky J, Simcha I, et al:
The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.
Proc Natl Acad Sci USA. 96:5522–5527. 1999. View Article : Google Scholar
|
|
30
|
Li TW, Ting JH, Yokoyama NN, Bernstein A,
van de Wetering M and Waterman ML: Wnt activation and alternative
promoter repression of LEF1 in colon cancer. Mol Cell Biol.
26:5284–5299. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin AY, Chua MS, Choi YL, et al:
Comparative profiling of primary colorectal carcinomas and liver
metastases identifies LEF1 as a prognostic biomarker. PLoS One.
6:e166362011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mei JM, Borchert GL, Donald SP and Phang
JM: Matrix metalloproteinase(s) mediate(s) NO-induced dissociation
of beta-catenin from membrane bound E-cadherin and formation of
nuclear beta-catenin/LEF-1 complex. Carcinogenesis. 23:2119–2122.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rivat C, Le Floch N, Sabbah M, et al:
Synergistic cooperation between the AP-1 and LEF-1 transcription
factors in activation of the matrilysin promoter by the src
oncogene: implications in cellular invasion. FASEB J. 17:1721–1723.
2003.PubMed/NCBI
|
|
34
|
Kriegl L, Horst D, Reiche JA, Engel J,
Kirchner T and Jung A: LEF-1 and TCF4 expression correlate
inversely with survival in colorectal cancer. J Transl Med.
8:1232010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sempere LF, Freemantle S, Pitha-Rowe I,
Moss E, Dmitrovsky E and Ambros V: Expression profiling of
mammalian microRNAs uncovers a subset of brain-expressed microRNAs
with possible roles in murine and human neuronal differentiation.
Genome Biol. 5:R132004. View Article : Google Scholar
|
|
36
|
Selbach M, Schwanhausser B, Thierfelder N,
Fang Z, Khanin R and Rajewsky N: Widespread changes in protein
synthesis induced by microRNAs. Nature. 455:58–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao C, Zhang Z, Liu W, Xiao S, Gu W and Lu
H: Reduced microRNA-218 expression is associated with high nuclear
factor kappa B activation in gastric cancer. Cancer. 116:41–49.
2010.PubMed/NCBI
|
|
38
|
Marracci GH, Jones RE, McKeon GP and
Bourdette DN: Alpha lipoic acid inhibits T cell migration into the
spinal cord and suppresses and treats experimental autoimmune
encephalomyelitis. J Neuroimmunol. 131:104–114. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Singh S, Narang AS and Mahato RI:
Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.
Pharm Res. 28:2996–3015. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Grimm D, Streetz KL, Jopling CL, et al:
Fatality in mice due to oversaturation of cellular microRNA/short
hairpin RNA pathways. Nature. 441:537–541. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Narayan G, Goparaju C, Arias-Pulido H, et
al: Promoter hypermethylation-mediated inactivation of multiple
Slit-Robo pathway genes in cervical cancer progression. Mol Cancer.
5:162006. View Article : Google Scholar : PubMed/NCBI
|
